NSight Dynamics s.r.l.

Who we are
NSight Dynamics is a spin-off company from the University of Florence, originating from the Department of Physics. Our mission, “Human Through Data,” is to transform human biology into actionable multimodal data through cutting-edge technologies that integrate human-centric AI, advanced physics, biology, and photonics.

What we do

• Biosignal analysis & multimodal data fusion
  We integrate multimodal biological and physiological data using advanced AI algorithms to predict health outcomes, detect early biomarkers, and support behavioural and clinical insights.

• Liquid Biopsy
  We are developing a proprietary photonics-based liquid biopsy platform (patent pending) enabling ultra-sensitive, scalable, and cost-effective diagnostic capabilities with potential applications in remote and early-stage health monitoring.

• Neurochip
  We design a hybrid neural chip that combines classical computation with novel AI architectures, offering high energy efficiency and scalability for future diagnostic, monitoring, and therapeutic applications.

Relevance to Horizon Europe – Cluster 1 (Health)
NSight Dynamics directly addresses several key priorities of Cluster 1, such as:

• early detection and diagnosis of diseases (neurological, neurodegenerative, oncological, systemic),

• development of next-generation medical technologies and point-of-care diagnostics,

• AI-driven analysis of complex biosignals and biological datasets,

• personalised and preventive health strategies.

Our interdisciplinary approach—bridging physics, photonics, biology, and AI—aligns strongly with Horizon Europe’s vision for transformative, integrated health solutions.

What we seek at the brokerage event

• Clinical partners (hospitals, neuroscience centres, medical research institutes) for validation and clinical studies.

• Academic partners for translational research, biomarker discovery, neurophysiology, systems biology, and public health studies.

• Industry partners in medtech / biotech for co-development, prototyping, scale-up, and industrialisation of diagnostic platforms and neurochips.

• Consortium partners for Horizon Europe proposals focused on diagnostics, brain health, personalised medicine, AI for health, and remote health monitoring.